Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.

Gynecologic oncology - 1 Sept 2004

Olawaiye Alexander, Caesar Lori, Walsh Debra, Lyman Mollie, Yeh John, Rodabaugh Kerry, Marchetti David, Lele Shashikant, Odunsi Kunle

Abstract excerpt

OBJECTIVES: The time interval between diagnoses of breast and epithelial ovarian cancer is not well established in women with dual primary tumors of both organ sites. Our goals were to examine the time interval between diagnoses and identify any relationship to clinicopathologic factors. METHODS: We identified 49 patients who developed both cancers. These patients were divided into two groups: group 1 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Neoplasm Staging

Share to Neoplasms, Second Primary

Share to Ovarian Neoplasms

Share to Peritoneal Neoplasms

Share to Time Factors

Source

Identifiers

PMID: 15350375
DOI: 10.1016/j.ygyno.2004.06.031

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.PMID 15350375Read ↗

Risk of second cancer among women with breast cancer.Semantic proximity Read ↗

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.Semantic proximity Read ↗

Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.Semantic proximity Read ↗

Risk factors for progression or death after first-line platinum-based chemotherapy in real-world patients in the USA with ovarian cancer from 2011 to 2018.Semantic proximity Read ↗

Risk factors for developing both primary breast and primary ovarian cancer: A systematic review.Semantic proximity Read ↗

Studying the Association Between Breast Cancer and Renal Cell CarcinomaSemantic proximity Read ↗

Identifying and screening patients at risk of second cancers.Semantic proximity Read ↗

BRCA1/2 status and clinicopathologic characteristics of patients with double primary breast and ovarian cancer.Semantic proximity Read ↗

"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Incidence of multiple primary malignancies in women diagnosed with breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.